Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-Cure in chronic ischemic heart failure
NCT02317458Phase 3Unknown
- Sponsor
- Celyad Oncology
- Start
- Jun 2017
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
01
Overview
A Phase 3 trial of C-Cure in chronic heart failure (CHF), sponsored by Celyad Oncology. Status: unknown.
02
Drugs
C-Cure
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT02317458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317458.